A personalized update on IgA nephropathy: a new vision and new future challenges
E Gutiérrez, F Carvaca-Fontán, L Luzardo, E Morales… - Nephron, 2020 - karger.com
IgA nephropathy (IgAN) is the most common primary glomerulonephritis in the world among
patients undergoing renal biopsy. Approximately 30% of patients with IgAN develop end …
patients undergoing renal biopsy. Approximately 30% of patients with IgAN develop end …
[引用][C] A Personalized Update on IgA Nephropathy: A New Vision and New Future Challenges
E Gutiérrez, F Carvaca-Fontán… - … Update on IgA …, 2020 - produccioncientifica.ucm.es
[PDF][PDF] A Personalized Update on IgA Nephropathy: A New Vision and New Future Challenges
E Gutiérreza, F Carvaca-Fontána, L Luzardod… - 2020 - researchgate.net
IgA nephropathy (IgAN) is the most common primary glomerulonephritis in the world among
patients undergoing renal biopsy. Approximately 30% of patients with IgAN develop end …
patients undergoing renal biopsy. Approximately 30% of patients with IgAN develop end …
A Personalized Update on IgA Nephropathy: A New Vision and New Future Challenges
E Gutiérrez, F Carvaca-Fontán, L Luzardo, E Morales… - Nephron, 2020 - karger.com
IgA nephropathy (IgAN) is the most common primary glomerulonephritis in the world among
patients undergoing renal biopsy. Approximately 30% of patients with IgAN develop end …
patients undergoing renal biopsy. Approximately 30% of patients with IgAN develop end …
[PDF][PDF] A Personalized Update on IgA Nephropathy: A New Vision and New Future Challenges
E Gutiérreza, F Carvaca-Fontána, L Luzardod… - 2020 - scholar.archive.org
IgA nephropathy (IgAN) is the most common primary glomerulonephritis in the world among
patients undergoing renal biopsy. Approximately 30% of patients with IgAN develop end …
patients undergoing renal biopsy. Approximately 30% of patients with IgAN develop end …
A Personalized Update on IgA Nephropathy: A New Vision and New Future Challenges
E Gutiérrez, F Carvaca-Fontán, L Luzardo… - …, 2020 - pubmed.ncbi.nlm.nih.gov
IgA nephropathy (IgAN) is the most common primary glomerulonephritis in the world among
patients undergoing renal biopsy. Approximately 30% of patients with IgAN develop end …
patients undergoing renal biopsy. Approximately 30% of patients with IgAN develop end …
A Personalized Update on IgA Nephropathy: A New Vision and New Future Challenges.
E Gutiérrez, F Carvaca-Fontán, L Luzardo, E Morales… - Nephron, 2020 - europepmc.org
IgA nephropathy (IgAN) is the most common primary glomerulonephritis in the world among
patients undergoing renal biopsy. Approximately 30% of patients with IgAN develop end …
patients undergoing renal biopsy. Approximately 30% of patients with IgAN develop end …